Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy ...

The Barbara Ann Karmanos Cancer Institute, a part of McLaren Health Care, has commenced the prescription of a new ...

The Barbara Ann Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of McLaren ...

Liver Cancer: Molecular Signaling Pathway of Tumor Development Decoded Apr. 23, 2024 — As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of ...

Advanced Biliary Tract Cancers Liver transplantation (LT) has been accepted as a cornerstone of care in hepatocellular carcinoma (HCC) for almost three decades. In recent years, its role has been ...

Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in ...

Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer - REDWOOD CITY, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- ...

The patient, diagnosed with a large hepatocellular carcinoma in the right lobe of the liver, faced significant challenges due ...

Liver cancer is a disease with a poor prognosis. Despite multiple therapeutic options, including the recent emergence of immunotherapy as a first-line systemic treatment, the outcomes remain poor.

Hepatocellular carcinoma (HCC) is a significant global health issue, ranking as the sixth most prevalent malignancy and the ...